- Home
- CLYM vs CIA Comparison
CLYM vs CIA Comparison
Compare CLYM & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLYM
- CIA
- Stock Information
- Founded
- CLYM 2018
- CIA 1969
- Country
- CLYM United States
- CIA United States
- Employees
- CLYM N/A
- CIA N/A
- Industry
- CLYM
- CIA Life Insurance
- Sector
- CLYM
- CIA Finance
- Exchange
- CLYM NYSE
- CIA Nasdaq
- Market Cap
- CLYM 201.7M
- CIA 230.6M
- IPO Year
- CLYM 2021
- CIA N/A
- Fundamental
- Price
- CLYM $1.82
- CIA $4.59
- Analyst Decision
- CLYM
- CIA
- Analyst Count
- CLYM 0
- CIA 0
- Target Price
- CLYM N/A
- CIA N/A
- AVG Volume (30 Days)
- CLYM 668.0K
- CIA 100.3K
- Earning Date
- CLYM 11-12-2024
- CIA 03-13-2025
- Dividend Yield
- CLYM N/A
- CIA N/A
- EPS Growth
- CLYM N/A
- CIA N/A
- EPS
- CLYM N/A
- CIA 0.43
- Revenue
- CLYM N/A
- CIA $248,376,000.00
- Revenue This Year
- CLYM N/A
- CIA N/A
- Revenue Next Year
- CLYM N/A
- CIA $3.85
- P/E Ratio
- CLYM N/A
- CIA $10.87
- Revenue Growth
- CLYM N/A
- CIA 3.02
- 52 Week Low
- CLYM $1.73
- CIA $1.78
- 52 Week High
- CLYM $11.55
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- CLYM N/A
- CIA 59.40
- Support Level
- CLYM N/A
- CIA $4.05
- Resistance Level
- CLYM N/A
- CIA $4.75
- Average True Range (ATR)
- CLYM 0.00
- CIA 0.21
- MACD
- CLYM 0.00
- CIA 0.06
- Stochastic Oscillator
- CLYM 0.00
- CIA 70.97
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.